Agios Pharmaceutical’s $905 Million Purchase Agreement for Vorasidenib Royalty

Leila Ahmed North America Legal Chronicle
Tagged:

Wilmer Cutler Pickering Hale and Dorr represented Agios Pharmaceuticals, Inc. in the deal.Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here